Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
17 results
  1. HIV Hospitalizations in 1998 and 2005 - Healthcare Cost and Utilization Project (HCUP) Statistical Briefs - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK56306
    ... therapies that include a protease inhibitor or a non-nucleoside reverse transcriptase inhibitors and at least one nucleoside reverse transcriptase inhibitor ( ...
  2. Detailed Methods - Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: A Systematic Review ... 
    https://www.ncbi.nlm.nih.gov/books/NBK542912
    ... et al. Effectiveness and safety of rilpivirine, a non-nucleoside reverse transcriptase inhibitor, in treatment-naive adults infected with HIV-1: ... et al. Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana. J Antimicrob ...
  3. HIV Medicines | HIV Cure | HIV Treatment | MedlinePlus 
    https://medlineplus.gov/hivmedicines.html
    ... inhibitors (NRTIs) block an enzyme called reverse transcriptase Non-nucleoside reverse transcriptase inhibitors (NNRTIs) bind to and later change reverse transcriptase ...
  4. xmlmplus_topics_2024-06-29.xml 
    https://medlineplus.gov/xml/mplus_topics_2024-06-29.xml
    ... an enzyme called reverse transcriptase</li> <li><strong>Non-nucleoside reverse transcriptase inhibitors (NNRTIs)</strong> bind to and later change reverse ...
  5. Studies Excluded Because They Did Not Have an Analysis for HIV+ Women >40 Years Old - Strategies for Improving the ... 
    https://www.ncbi.nlm.nih.gov/books/NBK401290
    ... 19110909 Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors J Natl Med Assoc Asad, ...
  6. NLM Digital Collections - Eighth (Amsterdam, Netherlands), 1992 Jul 19-24 
    https://resource.nlm.nih.gov/101647507X229
    ... controlled studies of d4T are currently in progress®, NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS Anumber of non-nucleoside Reverse Transcriptase inhibitors have ...
  7. NLM Digital Collections - American Red Cross, 1992 
    https://resource.nlm.nih.gov/101647507X142
    ... resistance problems encountered in early testing of other non-nucleoside reverse transcriptase inhibitors, Upjohn reported. The company explained that studies performed. ...
  8. NLM Digital Collections - Caring for "Ryan White" : the fundamentals of HIV/AIDS treatment policy 
    Publication: Washington, DC : National Health Policy Forum, [2005]
    resource.nlm.nih.gov/101263769
    ... otide reverse transcriptase inhibitors (NRTI) (ten drugs approved), non-nucleoside reverse transcriptase inhibitors (NNRTI) (three drugs approved), and fusion inhibitors (FI) ( ...
  9. NLM Digital Collections - Future Directions in AIDS Research (Madison, WI), 1993 July 30-31 
    https://resource.nlm.nih.gov/101647507X92
    ... research-based pharmaceutical companies are continuing Teseaich with non-nucleoside reverse transcriptase inhibitors, protease inhibitors, tat inhibitors, and nucleoside reverse transcriptase ...
  10. NLM Digital Collections - Drug Treatments, 1989-1992 
    https://resource.nlm.nih.gov/101647507X133
    ... with the experimental anti-HIV agents known as non-nucleoside reverse transcriptase inhibitors, the company has decided to refocus its efforts ...
previous · 1 · 2 · next